Moreover, currently we could not determine that BDNF is the only antidepressant target for oroxylin A yet, since the pathophysiology of depression involves dysfunction of many other systems besides monoaminergic and neurotrophic deficiency. The gene discussed is BDNF; the disease is depressive disorder.